JP2001501602A5 - - Google Patents

Download PDF

Info

Publication number
JP2001501602A5
JP2001501602A5 JP1998513899A JP51389998A JP2001501602A5 JP 2001501602 A5 JP2001501602 A5 JP 2001501602A5 JP 1998513899 A JP1998513899 A JP 1998513899A JP 51389998 A JP51389998 A JP 51389998A JP 2001501602 A5 JP2001501602 A5 JP 2001501602A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1998513899A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001501602A (ja
Filing date
Publication date
Priority claimed from US08/731,336 external-priority patent/US6153579A/en
Application filed filed Critical
Publication of JP2001501602A publication Critical patent/JP2001501602A/ja
Publication of JP2001501602A5 publication Critical patent/JP2001501602A5/ja
Ceased legal-status Critical Current

Links

JP10513899A 1996-09-12 1997-09-12 C型肝炎ウイルスns3プロテアーゼドメイン/ns4a複合体を含む結晶化可能な組成物およびその結晶 Ceased JP2001501602A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2527496P 1996-09-12 1996-09-12
US60/025,274 1996-10-18
US08/731,336 US6153579A (en) 1996-09-12 1996-10-18 Crystallizable compositions comprising a hepatitis C virus NS3 protease domain/NS4A complex
US08/731,336 1996-10-18
PCT/US1997/016182 WO1998011134A1 (en) 1996-09-12 1997-09-12 Crystallizable compositions comprising a hepatitis c virus ns3 protease domain/ns4a complex and crystals thereby obtained

Publications (2)

Publication Number Publication Date
JP2001501602A JP2001501602A (ja) 2001-02-06
JP2001501602A5 true JP2001501602A5 (https=) 2005-05-12

Family

ID=26699520

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10513899A Ceased JP2001501602A (ja) 1996-09-12 1997-09-12 C型肝炎ウイルスns3プロテアーゼドメイン/ns4a複合体を含む結晶化可能な組成物およびその結晶

Country Status (12)

Country Link
US (2) US6153579A (https=)
EP (1) EP0935609B1 (https=)
JP (1) JP2001501602A (https=)
AT (3) ATE244729T1 (https=)
AU (1) AU736857B2 (https=)
CA (1) CA2264964A1 (https=)
DE (3) DE69736995T2 (https=)
DK (1) DK0935609T3 (https=)
ES (2) ES2202228T3 (https=)
IL (1) IL128826A0 (https=)
PT (2) PT1118619E (https=)
WO (1) WO1998011134A1 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100509388B1 (ko) 1996-10-18 2005-08-23 버텍스 파마슈티칼스 인코포레이티드 세린 프로테아제, 특히 간염 c 바이러스 ns3 프로테아제의 저해제
JP2002534084A (ja) 1999-01-08 2002-10-15 ブリストル−マイヤーズ スクイブ カンパニー C型肝炎ウイルスns3プロテアーゼの修飾形
US6524589B1 (en) * 1999-04-08 2003-02-25 Schering Corporation Compositions of hepatitis C virus NS3/NS4A complex and methods for crystallizing same
AU775928B2 (en) 1999-10-14 2004-08-19 Bristol-Myers Squibb Company Crystallographic structure of the androgen receptor ligand binding domain
US7491808B2 (en) 2000-06-15 2009-02-17 Novartis Vaccines And Diagnostics, Inc. HCV non-structural protein mutants and uses thereof
MXPA02012605A (es) 2000-06-28 2003-05-14 Squibb Bristol Myers Co Moduladores selectivos del receptor androgeno y metodo para su identificacion, dise°o y uso.
SV2003000617A (es) * 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
JP2004535758A (ja) 2000-11-14 2004-12-02 ブリストル−マイヤーズ スクイブ カンパニー リンパ様細胞lsi−01から分泌される新規なヒトセルピンをコードするポリヌクレオチド
WO2002088303A2 (en) 2001-04-03 2002-11-07 Bristol-Myers Squibb Company Polynucleotide encoding a novel cysteine protease of the calpain superfamily, can-12, and variants thereof
US20030027315A1 (en) * 2001-09-24 2003-02-06 Ada Yonath Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, and methods of rationally designing or identifying antibiotics using structure coordinate data derived from such crystals
WO2005000308A2 (en) * 2003-05-15 2005-01-06 Rigel Pharmaceuticals, Inc. Methods of identifying hcv ns5b polymerase inhibitors and use against hepatitis c
TWI359147B (en) 2003-09-05 2012-03-01 Vertex Pharma Inhibitors of serine proteases, particularly hcv n
KR20060120166A (ko) 2003-10-27 2006-11-24 버텍스 파마슈티칼스 인코포레이티드 Hcv ns3-ns4a 단백질분해효소 저항성 돌연변이
US8187874B2 (en) 2003-10-27 2012-05-29 Vertex Pharmaceuticals Incorporated Drug discovery method
US8399615B2 (en) 2005-08-19 2013-03-19 Vertex Pharmaceuticals Incorporated Processes and intermediates
AR055395A1 (es) 2005-08-26 2007-08-22 Vertex Pharma Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
US7964624B1 (en) 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
EP2392589A3 (en) 2005-11-11 2012-06-20 Vertex Pharmaceuticals Incorporated Hepatitis C virus variants
US7705138B2 (en) 2005-11-11 2010-04-27 Vertex Pharmaceuticals Incorporated Hepatitis C virus variants
EP1991229A2 (en) 2006-02-27 2008-11-19 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
EP1993994A2 (en) * 2006-03-16 2008-11-26 Vertex Pharmceuticals Incorporated Deuterated hepatitis c protease inhibitors
US8440443B1 (en) 2006-05-16 2013-05-14 Merck Sharp & Dohme Corp. MEK1 polypeptides
DK2114924T3 (da) 2007-02-27 2012-04-10 Vertex Pharma Co-krystaller og farmaceutiske sammensætninger omfattende disse
JP2010519329A (ja) 2007-02-27 2010-06-03 バーテックス ファーマシューティカルズ インコーポレイテッド セリンプロテアーゼ阻害剤
CN101835774B (zh) 2007-08-30 2014-09-17 弗特克斯药品有限公司 共晶体和包含该共晶体的药物组合物
US8988881B2 (en) * 2007-12-18 2015-03-24 Sandia Corporation Heat exchanger device and method for heat removal or transfer
US9005417B1 (en) 2008-10-01 2015-04-14 Sandia Corporation Devices, systems, and methods for microscale isoelectric fractionation
US9795961B1 (en) 2010-07-08 2017-10-24 National Technology & Engineering Solutions Of Sandia, Llc Devices, systems, and methods for detecting nucleic acids using sedimentation
US9261100B2 (en) 2010-08-13 2016-02-16 Sandia Corporation Axial flow heat exchanger devices and methods for heat transfer using axial flow devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833233A (en) * 1987-08-20 1989-05-23 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Human serum albumin crystals and method of preparation
US5353236A (en) * 1992-04-23 1994-10-04 The Board Of Trustees Of The Leland Stanford University High-resolution crystallographic modelling of a macromolecule
US5453937A (en) * 1993-04-28 1995-09-26 Immunex Corporation Method and system for protein modeling
IT1272179B (it) * 1994-02-23 1997-06-16 Angeletti P Ist Richerche Bio Metodologia per riprodurre in vitro l'attivita' proteolitica della proteasi ns3 del virus hcv.

Similar Documents

Publication Publication Date Title
JP2000502280A5 (https=)
JP2000501771A5 (https=)
JP2000501599A5 (https=)
JP2000506047A5 (https=)
JP2000501018A5 (https=)
JP2000500076A5 (https=)
JP2000501324A5 (https=)
JP2000502472A5 (https=)
JP2000501338A5 (https=)
JP2000501825A5 (https=)
JP2000500874A5 (https=)
JP2000503304A5 (https=)
JP2000502425A5 (https=)
JP2000502485A5 (https=)
JP2000502568A5 (https=)
JP2000501774A5 (https=)
JP2000500912A5 (https=)
JP2000502570A5 (https=)
JP2000501876A5 (https=)
JP2000505072A5 (https=)
JP2000501744A5 (https=)
JP2000501229A5 (https=)
JP2000500857A5 (https=)
JP2001501602A5 (https=)
JP2000502316A5 (https=)